Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06808516
What this trial is testing

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Who this might be right for
Arginine Vasopressin DeficiencyCentral Diabetes InsipidusOxytocin Deficiency
University Hospital, Basel, Switzerland 42
Large-scale testing (Phase 3)Active Not RecruitingNCT07104500
What this trial is testing

VK2735 for Weight Management Phase 3

Who this might be right for
Weight Loss
Viking Therapeutics, Inc. 4,500
Testing effectiveness (Phase 2)Study completedNCT03985293
What this trial is testing

A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 412
Post-approval studies (Phase 4)Looking for participantsNCT06364930
What this trial is testing

SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 412
Large-scale testing (Phase 3)Temporarily pausedNCT01257412
What this trial is testing

Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 375
Early research (Phase 1)Study completedNCT01527565
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Large-scale testing (Phase 3)Ended earlyNCT01644201
What this trial is testing

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Who this might be right for
Type II Diabetes MellitusObesity
InovoBiologic Inc. 100
Early research (Phase 1)Study completedNCT01486901
What this trial is testing

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 44
Large-scale testing (Phase 3)Study completedNCT01272219
What this trial is testing

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 3,731
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Not applicableStudy completedNCT05720299
What this trial is testing

A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.

Who this might be right for
Prediabetes
Yu Chen 110
Post-approval studies (Phase 4)Study completedNCT01487798
What this trial is testing

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 170
Large-scale testing (Phase 3)Study completedNCT00765830
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Novartis 349
Testing effectiveness (Phase 2)WithdrawnNCT02490098
What this trial is testing

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal
Post-approval studies (Phase 4)Study completedNCT03662334
What this trial is testing

Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)

Who this might be right for
Type 1 Diabetes Mellitus
Halozyme Therapeutics 14
Early research (Phase 1)Study completedNCT00949091
What this trial is testing

Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 60
Not applicableNot Yet RecruitingNCT07609160
What this trial is testing

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

Who this might be right for
ObesitySarcopeniaOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Acibadem University 108
Not applicableStudy completedNCT05257460
What this trial is testing

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Who this might be right for
Type 1 Diabetes
University of Cambridge 28
Post-approval studies (Phase 4)Study completedNCT06851962
What this trial is testing

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus Type 2
Fundación para la Investigación del Hospital Clínico de Valencia 92
Next Page